Lilly Updates Warning Labels On Zyprexa and Symbyax

By Kevin Kingsbury

Word Count: 228 Companies Featured in This Article: Eli Lilly
Eli Lilly & Co. has updated the U.S. warning labels on Zyprexa and Symbyax to include new warnings for weight gain and hyperlipidemia and updated information in the label for hyperglycemia.
Lilly has spent more than $1 billion to settle claims about safety concerns regarding Zyprexa.